Evidence map›Paper›PMID 41515559›Full record

ArticleDiagnostics (Basel, Switzerland)2025

Longitudinal Comparison of Calprotectin and C-Reactive Protein in Rheumatoid Arthritis: Real-World Evidence Across Three Targeted Therapies.

Angelo Fassio, Isotta Galvagni, Silvia Sartoris, Denise Alessandra Cassandrini, Federico Aldegheri, Maurizio Rossini, Francesco Pollastri, Giovanni Adami, Davide Gatti, Rosanna Somma and 4 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Diagnostics (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Angelo FassioRheumatology Unit, University of Verona, 37126 Verona, Italy.
Isotta GalvagniRheumatology Unit, University of Verona, 37126 Verona, Italy.
Silvia SartorisImmunology Unit, University Hospital of Verona, 37126 Verona, Italy.
Denise Alessandra CassandriniImmunology Unit, University Hospital of Verona, 37126 Verona, Italy.
Federico AldegheriRheumatology Unit, University of Verona, 37126 Verona, Italy.ORCID 0009-0005-3965-5295
Maurizio RossiniRheumatology Unit, University of Verona, 37126 Verona, Italy.ORCID 0000-0001-9692-2293
Francesco PollastriRheumatology Unit, University of Verona, 37126 Verona, Italy.ORCID 0009-0006-1691-2196
Giovanni AdamiRheumatology Unit, University of Verona, 37126 Verona, Italy.
Davide GattiRheumatology Unit, University of Verona, 37126 Verona, Italy.ORCID 0000-0002-7471-3076
Rosanna SommaRheumatology Unit, University of Verona, 37126 Verona, Italy.
Matteo AppoloniRheumatology Unit, University of Verona, 37126 Verona, Italy.
Antonio CarlettoRheumatology Unit, University of Verona, 37126 Verona, Italy.
Vincenzo BronteImmunology Unit, University Hospital of Verona, 37126 Verona, Italy.ORCID 0000-0002-3741-5141
Alessandra ArcolaciImmunology Unit, University Hospital of Verona, 37126 Verona, Italy.ORCID 0000-0001-5567-4190

Funding

Italian Association for Cancer Research 23788Ministero della Salute J93C22002250006
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

biological disease-modifying antirheumatic drugscalprotectinC-reactive proteinrheumatoid arthritis

Identifiers

PMID41515559
PMCPMC12785770

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.